Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease-Reference-Cited by-同舟云学术

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

Published:2014-12-04 Issue:24 Volume:124 Page:3544-3552
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Uldrick Thomas S.¹,Polizzotto Mark N.¹,Aleman Karen¹,Wyvill Kathleen M.¹,Marshall Vickie²,Whitby Denise²,Wang Victoria¹,Pittaluga Stefania³,O’Mahony Deirdre¹,Steinberg Seth M.⁴,Little Richard F.¹,Yarchoan Robert¹

Affiliation:

1. HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD;

2. AIDS and Cancer Virus Program, Viral Oncology Section, Leidos-Frederick, National Cancer Institute, Frederick, MD; and

3. Laboratory of Pathology and

4. Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Abstract

Key PointsRituximab plus liposomal doxorubicin is active and tolerated in patients with symptomatic KSHV-associated multicentric Castleman disease. This is a safe and effective initial regimen for concurrent symptomatic KSHV-associated multicentric Castleman disease and Kaposi sarcoma.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/124/24/3544/1381543/3544.pdf

Reference67 articles.

1. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease.;Soulier;Blood,1995

2. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.;Uldrick;Blood,2011

3. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.;Polizzotto;Blood,2013

4. How I treat HIV-associated multicentric Castleman disease.;Bower;Blood,2010

5. Diagnostic criteria schemes for multicentric Castleman disease in 75 cases.;Bower;J Acquir Immune Defic Syndr,2014

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-10

2. HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus;Clinical Microbiology Reviews;2024-09-12

3. Factors affecting Kaposi’s sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study;2024-09-10

4. Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up;HemaSphere;2024-09

5. K _v 1.3-induced hyperpolarization is required for efficient Kaposi’s sarcoma–associated herpesvirus lytic replication;Science Signaling;2024-07-16